| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.500 | None | 0.944 | 2 | 7 | 1984 | 2020 | ||||||||
|
colony stimulating factor 1 receptor | 0.448 | 0.808 | 0.13 |
|
group | 0.500 | None | 0.960 | 1 | 4 | 1987 | 2020 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
group | 0.500 | None | 0.946 | 1 | 2 | 1995 | 2020 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
group | 0.500 | None | 0.964 | 1 | 0 | 1993 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.500 | None | 0.967 | 1 | 6 | 1983 | 2020 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
group | 0.500 | None | 0.956 | 1 | 0 | 1998 | 2020 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
group | 0.400 | None | 0.950 | 6 | 0 | 1992 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.400 | None | 0.953 | 2 | 0 | 1983 | 2020 | ||||||||
|
S-phase kinase associated protein 2 | 0.492 | 0.808 | 0.96 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.955 | 1 | 0 | 1994 | 2020 | ||||||||
|
aldo-keto reductase family 1 member B10 | 0.546 | 0.769 | 7.6E-09 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
peroxisome proliferator activated receptor alpha | 0.432 | 0.885 | 3.0E-02 |
|
group | 0.400 | None | 0.938 | 1 | 0 | 2000 | 2019 | ||||||||
|
plasminogen activator, urokinase receptor | 0.536 | 0.731 | 5.3E-03 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 1998 | 2017 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.400 | None | 0.947 | 1 | 0 | 1987 | 2020 | ||||||||
|
N-acetyltransferase 1 | 0.536 | 0.846 | 1.9E-14 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
group | 0.400 | None | 0.917 | 1 | 0 | 1997 | 2019 | ||||||||
|
interleukin 18 | 0.365 | 0.923 | 3.1E-02 |
|
group | 0.400 | None | 0.959 | 1 | 0 | 1999 | 2020 | ||||||||
|
solute carrier family 5 member 5 | 0.499 | 0.769 | 2.9E-03 |
|
group | 0.400 | None | 0.968 | 1 | 0 | 2000 | 2019 | ||||||||
|
apolipoprotein B mRNA editing enzyme catalytic subunit 3B | 0.547 | 0.731 | 5.2E-16 |
|
group | 0.400 | None | 0.963 | 1 | 0 | 1997 | 2019 | ||||||||
|
TNF receptor superfamily member 10a | 0.521 | 0.731 | 5.1E-15 |
|
group | 0.400 | None | 0.923 | 1 | 0 | 2001 | 2018 | ||||||||
|
lin-28 homolog A | 0.523 | 0.731 | 1.9E-02 |
|
group | 0.400 | None | 0.970 | 1 | 0 | 2009 | 2020 | ||||||||
|
YY1 transcription factor | 0.481 | 0.808 | 0.99 |
|
group | 0.400 | None | 0.929 | 1 | 0 | 1989 | 2019 | ||||||||
|
transient receptor potential cation channel subfamily V member 1 | 0.446 | 0.885 | 1.0E-16 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.400 | None | 0.968 | 1 | 0 | 1992 | 2020 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
group | 0.400 | None | 0.957 | 1 | 0 | 1999 | 2020 |